Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Certain substances can strongly inhibit DNA synthesis in hair cells.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Certain cytokines and growth factors can stop hair growth and may play a role in alopecia areata.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Antioxidants might help with Long Covid by addressing oxidative stress and nutrient imbalances.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Retinol may affect immune responses in people with frequent skin boils.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

The nanogel helps wounds heal without scars.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Activating TLR3 improves the healing and immune properties of periodontal ligament stem cells.

Targeting the AhR pathway may help treat alopecia areata.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.